{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T10:57:13Z","timestamp":1778324233492,"version":"3.51.4"},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1002\/jps.22486","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T23:55:24Z","timestamp":1295481324000},"page":"2979-2988","source":"Crossref","is-referenced-by-count":30,"title":["Development of a Canine Model to Enable the Preclinical Assessment of Ph-dependent Absorption of Test Compounds"],"prefix":"10.1016","volume":"100","author":[{"given":"R. Marcus","family":"Fancher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogdan","family":"Sleczka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Derbin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Rockar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Punit","family":"Marathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1002\/jps.22486_bb0005","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/mp100049m","article-title":"Dissolution rate and apparent solubility of poorly soluble drugs in biorelevant dissolution media","volume":"7","author":"Fagerberg","year":"2010","journal-title":"Mol Pharm"},{"issue":"2","key":"10.1002\/jps.22486_bb0010","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1021\/jm010152k","article-title":"Graphical model for estimating oral bioavailability of drugs in humans and other species from their Caco-2 permeability and in vitro liver enzyme metabolic stability rates","volume":"45","author":"Mandagere","year":"2002","journal-title":"J Med Chem"},{"issue":"1","key":"10.1002\/jps.22486_bb0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1011984216775","article-title":"Dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms","volume":"15","author":"Dressman","year":"1998","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.22486_bb0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11095-005-8476-1","article-title":"Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability\/bioequivalence studies","volume":"23","author":"Kalantzi","year":"2006","journal-title":"Pharm Res"},{"issue":"3","key":"10.1002\/jps.22486_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1021\/js960085v","article-title":"Physiochemical and physiological mechanisms for the effects of food on drug absorption: The role of lipids and pH","volume":"86","author":"Charman","year":"1997","journal-title":"J Pharm Sci"},{"issue":"1","key":"10.1002\/jps.22486_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/jps.20242","article-title":"Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility","volume":"94","author":"Gu","year":"2005","journal-title":"J Pharm Sci"},{"issue":"16","key":"10.1002\/jps.22486_bb0035","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1021\/jm030999b","article-title":"A physiological model for the estimation of the fraction dose absorbed in humans","volume":"47","author":"Willmann","year":"2004","journal-title":"J Med Chem"},{"issue":"3","key":"10.1002\/jps.22486_bb0040","first-page":"87","article-title":"Influence of concomitant food intake on the gastrointestinal absorption of fluconazole and itraconazole in Japanese subjects","volume":"14","author":"Zimmermann","year":"1994","journal-title":"Int J Clin Pharmacol Res"},{"issue":"4","key":"10.1002\/jps.22486_bb0045","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1023\/B:PHAM.0000022404.70478.4b","article-title":"A dynamic artificial gastrointestinal system for studying the behavior of orally administered drug dosage forms under various physiological conditions","volume":"21","author":"Blanquet","year":"2004","journal-title":"Pharm Res"},{"issue":"1\u20132","key":"10.1002\/jps.22486_bb0050","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5173(01)00663-9","article-title":"Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastrointestinal tract","volume":"221","author":"Kobayashi","year":"2001","journal-title":"Int J Pharm"},{"issue":"1","key":"10.1002\/jps.22486_bb0055","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0378-5173(02)00521-5","article-title":"Assessment of oral bioavailability enhancing approaches for SB-247083 using flow-through cell dissolution testing as one of the screens","volume":"250","author":"Perng","year":"2003","journal-title":"Int J Pharm"},{"issue":"Suppl 2","key":"10.1002\/jps.22486_bb0060","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/S0928-0987(00)00181-0","article-title":"In vitro\u2013in vivo correlations for lipophilic, poorly water-soluble drugs","volume":"11","author":"Dressman","year":"2000","journal-title":"Eur J Pharm Sci"},{"issue":"5","key":"10.1002\/jps.22486_bb0065","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res"},{"issue":"1","key":"10.1002\/jps.22486_bb0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1211\/0022357022511","article-title":"Predicting the precipitation of poorly soluble weak bases upon entry in the small intestine","volume":"56","author":"Kostewicz","year":"2004","journal-title":"J Pharm Pharmacol"},{"issue":"1","key":"10.1002\/jps.22486_bb0075","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1365-2036.2007.03545.x","article-title":"Four-day continuous gastric pH monitoring following antiacid secretory drug administration: Cross-over test to assess the early effects","volume":"27","author":"Suzuki","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"10","key":"10.1002\/jps.22486_bb0080","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0090-9556(25)06742-X","article-title":"Species similarities and differences in pharmacokinetics","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"10","key":"10.1002\/jps.22486_bb0085","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.2042-7158.1998.tb03317.x","article-title":"Different absorption profiles of deramciclane in man and in dog","volume":"50","author":"Kanerva","year":"1998","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"10.1002\/jps.22486_bb0090","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00464-008-0218-0","article-title":"Measurement of gastric pH in ambulatory esophageal pH monitoring","volume":"23","author":"Ayazi","year":"2009","journal-title":"Surg Endosc"},{"issue":"7","key":"10.1002\/jps.22486_bb0095","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1023\/A:1015827908309","article-title":"Upper gastrointestinal (GI) pH in young, healthy men, and women","volume":"7","author":"Dressman","year":"1990","journal-title":"Pharm Res"},{"issue":"7","key":"10.1002\/jps.22486_bb0100","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1007\/BF01297133","article-title":"Fasting gastric pH and its relationship to true hypochlorhydria in humans","volume":"36","author":"Feldman","year":"1991","journal-title":"Dig Dis Sci"},{"issue":"11","key":"10.1002\/jps.22486_bb0105","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/gut.31.11.1246","article-title":"Use of automatic computerised pump to maintain constant intragastric pH","volume":"31","author":"Hannan","year":"1990","journal-title":"Gut"},{"issue":"2","key":"10.1002\/jps.22486_bb0110","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0939-6411(99)00070-3","article-title":"Gastric pH profiles of beagle dogs and their use as an alternative to human testing","volume":"49","author":"Akimoto","year":"2000","journal-title":"Eur J Pharm Biopharm"},{"issue":"3","key":"10.1002\/jps.22486_bb0115","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/jps.2600750313","article-title":"Comparison of gastrointestinal pH in dogs and humans: Implications on the use of the beagle dog as a model for oral absorption in humans","volume":"75","author":"Lui","year":"1986","journal-title":"J Pharm Sci"},{"issue":"6","key":"10.1002\/jps.22486_bb0120","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1248\/cpb.38.1755","article-title":"Measurement of gastric pH during digestion of a solid meal in dogs","volume":"38","author":"Yamada","year":"1990","journal-title":"Chem Pharm Bull"},{"issue":"5","key":"10.1002\/jps.22486_bb0125","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"10.1002\/jps.22486_bb0130","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1079\/NRR19980005","article-title":"A review of the physiology of the canine digestive tract related to the development of in vitro systems","volume":"11","author":"Smeets-Peeters","year":"1998","journal-title":"Nutr Res Rev"},{"issue":"1","key":"10.1002\/jps.22486_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1254\/jjp.29.147","article-title":"Gastric acid secretion in beagle dogs using intramuscular injection of stimulants","volume":"29","author":"Hung","year":"1979","journal-title":"Jpn J Pharmacol"},{"issue":"8","key":"10.1002\/jps.22486_bb0140","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1018964117665","article-title":"Biopharmaceutics of didanosine in humans and in a model for acid-labile drugs, the pentagastrin-pretreated dog","volume":"10","author":"Knupp","year":"1993","journal-title":"Pharm Res"},{"issue":"11","key":"10.1002\/jps.22486_bb0145","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1248\/cpb.38.3112","article-title":"Gastric acidity-dependent bioavailability of commercial sustained release preparations of indomethacin, evaluated by gastric acidity-controlled beagle dogs","volume":"38","author":"Yamada","year":"1990","journal-title":"Chem Pharm Bull"},{"issue":"7","key":"10.1002\/jps.22486_bb0150","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0090-9556(25)06651-6","article-title":"pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats, and dogs","volume":"23","author":"Lin","year":"1995","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1002\/jps.22486_bb0155","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1248\/cpb.37.3372","article-title":"Effect of gastric acidity on bioavailability of N,N-dimethylcarbamoylmethylalpha, 2-dimethyl-5H-[1]benzopyrano[2,3-b]pyridine-7-acetate, a new prodrug-type anti-inflammatory agent","volume":"37","author":"Yamada","year":"1989","journal-title":"Chem Pharm Bull"},{"issue":"1","key":"10.1002\/jps.22486_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ejpb.2007.10.010","article-title":"In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets","volume":"69","author":"Zhang","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"issue":"2","key":"10.1002\/jps.22486_bb0165","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1007\/s11095-004-1185-3","article-title":"pH-dependent dissolution in vitro and absorption in vivo of weakly basic drugs: Development of a canine model","volume":"22","author":"Zhou","year":"2005","journal-title":"Pharm Res"},{"key":"10.1002\/jps.22486_bb0170","series-title":"Guidance for industry: Food-effect bioavailability and fed bioequivalence studies","author":"FDA","year":"2002"},{"issue":"2","key":"10.1002\/jps.22486_bb0175","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1002\/jps.20767","article-title":"Development and validation of a preclinical food effect model","volume":"96","author":"Lentz","year":"2007","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.22486_bb0180","series-title":"Pharmacokinetics","author":"Gibaldi","year":"1982"},{"issue":"8","key":"10.1002\/jps.22486_bb0185","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/00045391-199508000-00006","article-title":"Effects of aluminum\/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn","volume":"2","author":"Decktor","year":"1995","journal-title":"Am J Ther"},{"issue":"6","key":"10.1002\/jps.22486_bb0190","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1046\/j.1365-2036.1997.00264.x","article-title":"Intragastric pH after oral administration of single doses of ranitidine effervescent tablets, omeprazole capsules and famotidine fast-dissolving tablets to fasting healthy volunteers","volume":"11","author":"Hedenstrom","year":"1997","journal-title":"Aliment Pharm Ther"},{"key":"10.1002\/jps.22486_bb0195","series-title":"Basic and clinical pharmacology","author":"Katzung","year":"2007"},{"issue":"2","key":"10.1002\/jps.22486_bb0200","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1365-2036.1994.tb00278.x","article-title":"Comparison of acid inhibition by either oral high-dose ranitidine or omeprazole","volume":"8","author":"Hurlimann","year":"1994","journal-title":"Aliment Pharm Ther"},{"issue":"6","key":"10.1002\/jps.22486_bb0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-2036.1995.tb00434.x","article-title":"Twenty-four-hour intragastric acidity: 300mg ranitidine b.d., 20mg omeprazole o.m., 40mg omeprazole o.m. versus placebo","volume":"9","author":"Houben","year":"1995","journal-title":"Aliment Pharm Ther"},{"issue":"7","key":"10.1002\/jps.22486_bb0210","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.21602","article-title":"Fed and fasted gastric pH and gastric residence time in conscious beagle dogs","volume":"98","author":"Sagawa","year":"2009","journal-title":"J Pharm Sci"},{"issue":"9","key":"10.1002\/jps.22486_bb0215","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1248\/cpb.37.2539","article-title":"Gastric pH profile and its control in fasting beagle dogs","volume":"37","author":"Yamada","year":"1989","journal-title":"Chem Pharm Bull"},{"key":"10.1002\/jps.22486_bb0220","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0378-5173(88)90057-9","article-title":"Gastric emptying of liquids in the fasted dog","volume":"43","author":"Gupta","year":"1988","journal-title":"Int J Pharm"},{"issue":"11","key":"10.1002\/jps.22486_bb0225","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.2042-7158.1986.tb04498.x","article-title":"Effect of particle size and food on gastric residence time of non-disintegrating solids in beagle dogs","volume":"38","author":"Itoh","year":"1986","journal-title":"J Pharm Pharmacol"},{"issue":"8","key":"10.1002\/jps.22486_bb0230","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1248\/bpb1978.11.563","article-title":"Gastric emptying rates of drug preparations. I. Effects of size of dosage forms, food and species on gastric emptying rates","volume":"11","author":"Kaniwa","year":"1988","journal-title":"J Pharmacobiodyn"},{"issue":"4","key":"10.1002\/jps.22486_bb0235","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/0016-5085(85)90576-1","article-title":"Effect of size and density on canine gastric emptying of nondigestible solids","volume":"89","author":"Meyer","year":"1985","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1002\/jps.22486_bb0240","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.addr.2004.02.013","article-title":"Companion animal physiology and dosage form performance","volume":"56","author":"Sutton","year":"2004","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.22486_bb0245","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00365528709090142","article-title":"Famotidine: A notable lack of drug interactions","volume":"134","author":"Humphries","year":"1987","journal-title":"Scand J Gastroenterol Suppl"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915320505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T23:17:17Z","timestamp":1740871037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915320505"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0022354915320505"],"URL":"https:\/\/doi.org\/10.1002\/jps.22486","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}